Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited ( (AU:EBO) ) just unveiled an update.
EBOS Group Limited has issued 12,424 unquoted performance rights under its employee incentive scheme, effective 23 March 2026. The new allocation, which will not be quoted on the ASX, underscores the company’s continued use of equity-based incentives to align staff remuneration with long-term corporate performance and shareholder interests.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$29.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a healthcare and pharmaceutical distribution company listed on the ASX under the code EBO. The group is involved in supplying healthcare products and services across its markets, supporting pharmacies, medical providers and related sectors through logistics, distribution and associated solutions.
Average Trading Volume: 155,102
Technical Sentiment Signal: Sell
Current Market Cap: A$3.73B
See more insights into EBO stock on TipRanks’ Stock Analysis page.